The advertisement promotes VYVGART Hytrulo as the first and only self-injection treatment for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), highlighting its quick administration time.
Creative Information
| CID: | 207aca77-578f-4ae0-8053-a3651f7921f4 |
| CRID: | 29_616826358 |
| Domain: | vyvgart.com |
| Seat: | Xandr |
| Size: | 300x600 |
| Bid: | $0.21 |
| Timestamp: | 11/4/2025, 5:00:46 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 12/18/2025, 8:58:26 PM | 5.73s | |
| adomain_analysis | success | 12/18/2025, 8:58:27 PM | 5.25s | |
| adomain_capture | success | 12/18/2025, 8:58:21 PM | 0.23s | |
| ad_render | success | 12/18/2025, 8:58:20 PM | 30.86s | |
| brand_mapping | success | 12/18/2025, 8:57:49 PM | 0.11s | |
Analysis Results
Ad Format: banner
Brands: Vyvgart
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x600 | ||||||||||||||||||||||
| Data Transferred: | 1444.07 KB | ||||||||||||||||||||||
| Render Time: | 9.03 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1444.32 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives
